LIBERTAS

A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC

ApalutamideOngoingActive not recruitingPhase 3Open NCT05884398 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…